FdaApplication
NDA 209305
Identifiers
- fda_app_no: NDA209305
Properties
| Property | Value |
|---|---|
| applicant_name | ACLARIS THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2017-12-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESKATA | HYDROGEN PEROXIDE | 40% | SOLUTION;TOPICAL |
1 product